Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls

Schizophrenia Research

Volumn 105, Issue 1-3, 2008, Pages 287-288

  Yarlagadda, Atmaram ^a   Helvink, Badalin ^a   Chou, Caroline ^a   Gladieux, Kenneth ^a   Keller, Adrienne ^b   Clayton, Anita ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; AGED; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SEROLOGY; STUDENT T TEST; TARDIVE DYSKINESIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONTROL GROUPS; DYSKINESIA, DRUG-INDUCED; GLUTAMATE DECARBOXYLASE; HUMANS; MIDDLE AGED; SCHIZOPHRENIA;

EID: 52949118133     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.06.019     Document Type: Letter

References (8)

1. 65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20 3-4 (2000) 259-269
2. Dalakas M.C. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol 252 suppl 1 (2005) 19-25
3. Hampe C.S., et al. Species-specific autoantibodies in type I diabetes. J. Clin. Endocrinol. Metab. 84 (1999) 643-648
4. Hashimoto T., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23 15 (2003) 6315-6326
5. Lewin G.R., and Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19 (1996) 289-317
6. Meinck H.-M., et al. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J. Neurol. Neurosurg. Psychiatry 71 (2001) 100-103
7. Padmos R.C., et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol. Psychiatry 56 7 (2004) 476-482
8. Tan Y.L., et al. Decreased plasma brain-derived neurotropic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr. Res. 74 2-3 (2004) 263-270